PHASE 3, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED
Clinical Trial Grant
Administered By
Obstetrics and Gynecology, Maternal Fetal Medicine
Awarded By
Pfizer, Inc.
Start Date
June 8, 2020
End Date
April 16, 2024
Administered By
Obstetrics and Gynecology, Maternal Fetal Medicine
Awarded By
Pfizer, Inc.
Start Date
June 8, 2020
End Date
April 16, 2024